Cost Effectiveness and Efficacy of Standalone Stents as Second-Stage Surgery Study: SUCCESSES

Not Applicable

Recruiting

• Conditions: Glaucoma; Cataract; Primary open angle glaucoma; Ocular hypertension; Cataract Surgery; Eye - Diseases / disorders of the eye; Surgery - Other surgery

• Registration Number: ACTRN12622000492752
• Lead Sponsor: Dr Jesse Gale

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-03-28
• Last Update Posted: 6 March 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 97

Inclusion Criteria

1. Visually significant cataract requiring surgery with visual acuity (VA) 6/9 or worse. Important issues about equity of access to cataract surgery are addressed below.
2. Diagnosis of Ocular Hypertension (OHT) or mild to moderate open angle glaucoma (including primary open angle, pigment dispersion, pseudoexfoliation), taking at least one topical glaucoma medication (eye drops)
3. Target IOP greater than or equal to 15 mmHg
4. Either a) IOP over target; OR b) at least one recognisable side effect of drops
5. Willing and able to give informed consent
6. Age greater than 18yrs

Exclusion Criteria

1. Low tension, angle closure, neovascular, uveitic, traumatic or other secondary glaucoma
2. Prior incisional glaucoma surgery or cyclodestructive procedure
3. Selective laser trabeculoplasty (SLT) performed within 60 days of recruitment
4. Inability to safely perform iStent implantation, such as corneal opacity impeding gonioscopy view of nasal angle
5. Inability to attend follow up

Study & Design

• Study Type: Interventional
• Study Design: Not specified